Markets
BSE See NSE See 40,544.37
112.77 (0.28%)

Ranbaxy Laboratories Ltd. Industry : (Pharmaceuticals)

Quick Glance

Listed on BSE
  • Market Cap 0Crores
  • Book Value 0
  • Face Value 5
  • Current Price 859.90
  • % Change 5.63
  • 52 week H/L 0/ 0
  • TTM P/E 0.00
  • Dividend Yield 0 %

Stock vs. Index

Price History

You can view historic prices (Open,High,Low,Close) of the company for the range of days

Company
Analysis

Potential For Generating Electrifying Returns!

Jul 18, 2019

The privatization of electricity distribution in India is speeding up, ther


Shareholding Pattern


Expert
Interview

DSIJ Interview With Kedar Upadhye CFO, Cipla LTD.

Vol 34 Issue No 19 | Aug 14, 2019

I would highlight [a] intelligent capital allocation to support growth acro


collapse Financial Performance collapse

Quarterly Results

(All figures In Rs. Cr.) Sep 12 Dec 12 Mar 13 Jun 13 Sep 13 Dec 13 Mar 14 Jun 14 Dec 14
Sales 1469.65 1441.52 1381.64 1438.89 1425.84 1366.56 1252.02 2178.63 1009.85
Other Income 57.71 67.11 52.33 31.04 44.35 20.60 636.50 25.76 17.75
Operating Profit 231.14 -87.55 31.88 -150.78 -101.87 -66.05 -37.66 926.39 -351.50
Interest -17.38 134.29 50.60 156.13 111.08 118.39 110.85 141.91 149.31
Depreciation 44.36 46.39 45.29 44.65 94.41 45.85 49.98 65.65 54.81
Taxation 0.00 -1.94 0.00 0.00 0.00 0.00 30.57 9.24 855.35
Net Profit / Loss 552.19 -616.10 70.15 -608.81 -842.23 -395.96 897.86 755.12 -1420.49

Annual Results

(All figures In Rs. Cr.) Dec 05 Dec 06 Dec 07 Dec 08 Dec 09 Dec 10 Dec 11 Dec 12 Mar 14
Sales 3490.13 3973.56 4071.29 4494.52 4782.76 5672.10 7690.12 6303.54 6864.94
Other Income 209.66 79.57 439.70 91.26 276.39 360.33 346.26 239.60 784.82
Operating Profit 65.76 559.45 546.87 239.75 823.89 1232.88 1255.00 460.49 -324.48
Interest 26.41 58.10 93.43 893.40 -109.85 54.19 603.56 296.98 547.05
Depreciation 101.33 111.76 118.73 125.39 148.20 228.35 274.08 186.16 280.17
Taxation -22.34 60.11 156.69 -594.37 489.93 416.52 3.38 -1.94 30.57
Net Profit / Loss 223.70 386.45 617.72 -1032.33 571.98 1148.73 -3052.05 -162.34 -879.00

Compounded Sales & Net Profit Growth

Period Sales % Net Profit %
TTM 2.10% NA
1 Years 8.91% NA
2 Years -5.52% NA
3 Years 6.57% NA
4 Years 9.46% NA
5 Years 8.84% NA

Investor Returns

Type Ratio / % Date
Dividend
40.00
28 Apr 2011
Bonus
3:5
01 Oct 2002
Rights
9:100
18 Oct 1991
Split
10:5
25 Jul 2005

Announcements

Date Title
Mar 06, 2020 Meghmani Organics still playing safe from Coronavirus
Jan 22, 2020 Closing bell: Sensex erase gain by ending 200 points lower
Mar 15, 2019 SC asks ex-Ranbaxy promoters to submit a concrete plan for paying Rs 3,500 crore to Daiichi Sankyo
Mar 25, 2015 Ranbaxy Labs. - Fixes Record Date for Scheme of Amalgamation
Mar 25, 2015 Ranbaxy Laboratories Ltd. - Suspension of trading in equity shares

collapse Peer Review collapse

Peer Companies

Company CMP (Rs.) % Change Market Cap (Rs. Cr.) 52 Week H/L Book Value (Rs.) PE (x)
1 2 3 4 5 >
Sun Pharmaceutical Industries Ltd.
486.40
0.50%
116,703.65
564.90 / 315.20
188.65
31.00
Dr. Reddy's Laboratories Ltd.
5,069.35
0.35%
84,287.72
5,514.65 / 2,497.60
938.17
41.60
Divi's Laboratories Ltd.
3,086.95
-0.19%
81,948.82
3,388.00 / 1,627.15
275.36
59.53
Cipla Ltd.
764.05
0.03%
61,610.38
829.00 / 356.75
195.48
39.84
Biocon Ltd.
440.30
0.61%
52,836.00
477.90 / 235.80
55.87
70.62
Aurobindo Pharma Ltd.
798.60
-0.08%
46,793.06
967.60 / 281.15
286.90
16.53
Torrent Pharmaceuticals Ltd.
2,708.15
1.31%
45,828.05
3,040.00 / 1,619.00
285.02
44.72
Lupin Ltd.
1,009.00
-0.48%
45,731.95
1,121.85 / 505.00
271.87
0.00
Cadila Healthcare Ltd.
428.00
1.30%
43,816.18
447.95 / 212.70
101.35
37.24
Abbott India Ltd.
15,800.00
-0.34%
33,573.90
18,569.00 / 10,383.00
1,144.37
56.62